Medical News

RSS
Oragenics awarded additional $500,000 to further development of MU 1140, DPOLT antibiotics platform

Oragenics awarded additional $500,000 to further development of MU 1140, DPOLT antibiotics platform

PHC's Board of Directors authorize repurchase of up to one million shares of Class A common stock

PHC's Board of Directors authorize repurchase of up to one million shares of Class A common stock

DV Biologics executes agreement with System Biosciences to develop iPSC lines

DV Biologics executes agreement with System Biosciences to develop iPSC lines

FDA clears U.Va.'s SpermCheck Fertility at-home test

FDA clears U.Va.'s SpermCheck Fertility at-home test

Telormedix initiates Phase I/II clinical study of TMX-101 for treating NMIBC

Telormedix initiates Phase I/II clinical study of TMX-101 for treating NMIBC

'Micro-ear' to screen for malaria, sleeping sickness

'Micro-ear' to screen for malaria, sleeping sickness

UBC earns high ratings in 2010 late phase market dynamics survey

UBC earns high ratings in 2010 late phase market dynamics survey

New research evaluating substantial disease burden of PNH presented at European Hematology Association

New research evaluating substantial disease burden of PNH presented at European Hematology Association

Biodel announces schedule for presentations at 70th Scientific Sessions of American Diabetes Association

Biodel announces schedule for presentations at 70th Scientific Sessions of American Diabetes Association

Parents are little aware of concussion risks and support school policies to minimize them: Poll

Parents are little aware of concussion risks and support school policies to minimize them: Poll

Cintas issues tips for maintaining secure, compliant EMRs

Cintas issues tips for maintaining secure, compliant EMRs

Patients beginning therapy on popular osteoporosis drugs discontinue treatment within 6 months: Report

Patients beginning therapy on popular osteoporosis drugs discontinue treatment within 6 months: Report

Medidata Solutions launches new RTSM solution for clinical research sponsors, sites

Medidata Solutions launches new RTSM solution for clinical research sponsors, sites

IMF concludes first-of-its-kind inaugural Myeloma Summit

IMF concludes first-of-its-kind inaugural Myeloma Summit

Successful go live of HCIM's SymKey Professional Claims, Virtual Auto-Post modules at MedPOINT Management

Successful go live of HCIM's SymKey Professional Claims, Virtual Auto-Post modules at MedPOINT Management

Study evaluates correlation between EverOn system and detection of patient deterioration in hospitals

Study evaluates correlation between EverOn system and detection of patient deterioration in hospitals

Total Immersion adds Eveo as Certified D'Fusion Reseller to partner network

Total Immersion adds Eveo as Certified D'Fusion Reseller to partner network

BioClinica eClinical Technology Suite and BIOP to be showcased at DIA Annual Meeting

BioClinica eClinical Technology Suite and BIOP to be showcased at DIA Annual Meeting

A.M. Best affirms ratings of ProAssurance

A.M. Best affirms ratings of ProAssurance

Abstract on Phase I/II DIGNITY trial of ThermoDox in RCW Breast Cancer accepted at ASTRO 2010

Abstract on Phase I/II DIGNITY trial of ThermoDox in RCW Breast Cancer accepted at ASTRO 2010

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.